An IHC-based study investigating tissue from 45 patients with ovarian tumors of low-malignant potential and 89 patients with ovarian cancers showed a higher expression of GPER1 in tumors of higher stage and grade [112]. Here, GPER1 is linked to ovarian neoplasm.